Published in Transplant Proc on December 01, 1996
Therapeutic drug monitoring of immunosuppressant drugs. Br J Clin Pharmacol (1999) 0.83
Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol (2002) 3.91
Induction of xenoreactive CD4+ T-cell anergy by suppressor CD8+CD28- T cells. Transplantation (2000) 1.60
Kidney instant monitoring (K.IN.G): a new analyzer to monitor kidney function. Minerva Anestesiol (2010) 1.47
Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28- T cells. Int Immunol (1998) 1.44
Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+CD28- regulatory T cells. J Immunol (1998) 1.30
Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest (1998) 1.30
T suppressor lymphocytes inhibit NF-kappa B-mediated transcription of CD86 gene in APC. J Immunol (1999) 1.17
Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest (1996) 1.16
Liver transplantation in hepatitis delta virus disease. Lancet (1987) 1.02
Alternative laparoscopic management of perforated peptic ulcers. Surg Endosc (1994) 0.94
Alpha interferon therapy in patients with hepatitis infection undergoing organ transplantation. Transplant Proc (1989) 0.91
CD8(+)CD28(-) T suppressor cells represent a distinct subset in a heterogeneous population. Transplant Proc (2001) 0.89
Mechanism of liver allograft rejection: the indirect recognition pathway. Hum Immunol (1997) 0.89
Inhibition of CD40 signaling pathway in antigen presenting cells by T suppressor cells. Hum Immunol (1999) 0.88
Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro. Hum Immunol (1998) 0.88
Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation. Transpl Immunol (2007) 0.88
Detection of T suppressor cells in patients with organ allografts. Hum Immunol (2001) 0.87
New approaches to specific immunomodulation in transplantation. Int Rev Immunol (1996) 0.86
Hemodynamics during inhaled nitric oxide in lung transplant candidates. Transplant Proc (1997) 0.86
Distinct mRNA microarray profiles of tolerogenic dendritic cells. Hum Immunol (2001) 0.86
Regulation of ILT3 gene expression by processing of precursor transcripts in human endothelial cells. Am J Transplant (2006) 0.86
Lymphocyte and blast cell glomerulonephritis in renal allografts of rats injected with phytohaemagglutinin. Cell Immunol (1974) 0.86
Human decay accelerating factor transgenic pigs for xenotransplantation obtained by sperm-mediated gene transfer. Transplant Proc (1999) 0.85
Indirect allorecognition of donor HLA-DR peptides in chronic rejection of heart allografts. Transplant Proc (1998) 0.85
Cloning and functional characterization of the 5'-regulatory region of the human CD86 gene. Hum Immunol (2000) 0.82
TCR repertoire of suppressor CD8+CD28- T cell populations. Hum Immunol (1999) 0.82
Intramolecular and intermolecular spreading during the course of organ allograft rejection. Immunol Rev (1998) 0.81
Bench surgery for multiple renal arteries in kidney transplantation from living donor. Transplant Proc (1991) 0.81
Persistent allopeptide reactivity and epitope spreading in chronic rejection. Transplant Proc (1998) 0.81
Giant hemangiomas of the liver: surgical strategies and technical aspects. HPB (Oxford) (2006) 0.80
[Rupture of hydatid cyst with invasion of the bile ducts and acute pancreatitis]. G Chir (1989) 0.79
Immunoadsorption with protein A in humoral rejection of kidney transplants. ASAIO J (1997) 0.79
Mechanism of liver allograft rejection: indirect allorecognition. Transplant Proc (1999) 0.79
Calcium oxalate microdeposition in failing kidney grafts. Transplant Proc (2001) 0.79
Persistent allopeptide reactivity and epitope spreading in chronic rejection. Transplant Proc (1999) 0.79
Sperm-mediated gene transfer: production of pigs transgenic for a human regulator of complement activation. Transplant Proc (1997) 0.79
Efficiency of transgenesis using sperm-mediated gene transfer: generation of hDAF transgenic pigs. Transplant Proc (2000) 0.79
CD8(+)CD28(-) T cells suppress alloresponse of CD4(+) T cells both in primates and rodents. Transplant Proc (2001) 0.79
New strategies for early diagnosis of heart allograft rejection. Transplantation (1997) 0.79
Organizzazione Centro-Sud Trapianti: outcome analysis 1999 to 2002. Transplant Proc (2004) 0.79
hDAF expression in hearts of transgenic pigs obtained by sperm-mediated gene transfer. Transplant Proc (2000) 0.78
Clinical transplantation. Transplant Proc (1979) 0.78
Hemodynamic-volumetric versus pulmonary artery catheter monitoring during anesthesia for liver transplantation. Transplant Proc (2001) 0.78
Patterns of immune response in well tolerated renal grafts. Transplant Proc (1978) 0.78
Pediatric renal transplantation: anesthesia and perioperative complications. Pediatr Surg Int (2001) 0.78
Mapping of dominant HLA-DR determinants recognized via the indirect pathway. Transplant Proc (1997) 0.78
Mice transgenic for human CD46 and CD55 are protected from human complement attack. Transplant Proc (1995) 0.78
Specific T-cell deletion by transfected human monocytes expressing Fas ligand and antigen. Transplant Proc (2001) 0.78
Kidneys derived from mice transgenic for human complement blockers are protected in an in vivo model of hyperacute rejection. J Urol (1998) 0.78
Human xenospecific T suppressor cells inhibit T helper cell proliferation to porcine aortic endothelial cells, and NF-kappaB activity in porcine APC. Hum Immunol (2001) 0.77
Living unrelated kidney transplantation: a 12-year single center experience. Transplant Proc (1997) 0.77
Kidney transplantation from living unrelated donors. Clin Transpl (1998) 0.77
Homing of CD4+CD56+ T lymphocytes into kidney allografts during tubular necrosis or rejection. Clin Transplant (1995) 0.77
Use of MARS in the treatment of acute liver failure: preliminar monocentric experience. Transplant Proc (2001) 0.77
Enhanced production of interferon-gamma by T lymphocytes cloned from rejected kidney grafts. Transplantation (1991) 0.77
Role of the indirect recognition pathway in the development of chronic liver allograft rejection. Transplant Proc (1998) 0.77
Oxygen delivery and oxygen tension in cerebral tissue during global cerebral ischaemia: a swine model. Acta Neurochir Suppl (2000) 0.76
Indirect allorecognition in solid organ transplantation. Rev Immunogenet (1999) 0.76
Indirect T-cell recognition in human allograft rejection. Transplant Proc (1997) 0.76
Allopeptide-specific T cell reactivity altered by peptide analogs. J Immunol (1997) 0.76
Similarity of pulmonary rejection patterns among heart-lung and double-lung transplant recipients. Transplantation (1991) 0.76
Intravascular transplantation of microencapsulated islets in diabetic dogs. Transplant Proc (1992) 0.76
Diltiazem affects human dendritic cell maturation. Transplant Proc (2001) 0.76
Early enteral immunonutrition vs. parenteral nutrition in critically ill patients without severe sepsis: a randomized clinical trial. Intensive Care Med (2006) 0.76
The use of indomethacin to treat acute rises of intracranial pressure and improve global cerebral perfusion in a child with head trauma. Acta Anaesthesiol Scand (1997) 0.76
Extracorporal liver perfusion as hepatic assist in acute liver failure: a review of world experience. Xenotransplantation (2003) 0.75
Inhaled areosolized prostacyclin and pulmonary hypertension during anesthesia for lung transplantation. Transplant Proc (2001) 0.75
Heat stress: characteristics, pathophysiology and avoidable mistakes. Minerva Anestesiol (2004) 0.75
Perfusion time anuria and nephrotoxicity in cadaveric renal transplant. Contrib Nephrol (1986) 0.75
Liver transplantation. Life Support Syst (1985) 0.75
[Transplantation of the kidney]. Recenti Prog Med (1968) 0.75
Phenotypic and functional comparative analysis between infiltrating kidney transplant and peripheral blood immunocompetent cells after allograft nephrectomy. Transplant Proc (1988) 0.75
New frontiers of transplantation. Transplant Proc (1979) 0.75
Perspectives on heart substitution: temporary implantation of artificial heart followed by heart allograft. Transplant Proc (1977) 0.75
A new approach to current problems in organ donation for kidney transplantation. Contrib Nephrol (1986) 0.75
[Technic of preparation of antithymocytic globulin]. Recenti Prog Med (1968) 0.75
[Immunological profile of high-risk patients treated with different types of immunosuppressive therapy]. Ann Ist Super Sanita (1987) 0.75
Monitoring and modulation of recipient immune responsiveness to prevent kidney graft rejection in the early post-transplant period. Proc Eur Dial Transplant Assoc (1977) 0.75
Comparison of three immunosuppressive regimens in high-risk patients: immunologic aspects. Transplant Proc (1987) 0.75
[Alternatives to heart transplantation]. Cardiologia (1986) 0.75
Delta reinfection in human liver transplantation: report of two cases. Prog Clin Biol Res (1987) 0.75
Immunosuppressive therapy in high-risk patients. Contrib Nephrol (1986) 0.75
[Differential diagnosis of rejection and cyclosporin nephrotoxicity in organ transplantation using exfoliative urinary cytology]. Quad Sclavo Diagn (1985) 0.75
Immunological reactivity of peripheral lymphocytes in kidney transplant patients. Ric Clin Lab (1977) 0.75
[Liver transplantation: physiopathological study of the hepatoprival phase]. Policlinico Chir (1969) 0.75
[Technical aspects of periodic hemodialysis in the treatment of chronic uremia]. Minerva Med (1967) 0.75
Heart transplantation in children: initial experience at University of Rome. Transplant Proc (1987) 0.75
Experiences on heart substitution with natural and artificial heart. Transplant Proc (1976) 0.75
Clinical experience with ciclosporin at the Rome University Hospital. Contrib Nephrol (1986) 0.75
The clinical relevance of pretransplant recipient immunoresponsiveness in renal transplantation: impact on rejection. Transplant Proc (1996) 0.75